• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.03% Nasdaq Up 0.33%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    7.75 Up 0.03(0.39%) Jul 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:7.72
    Open:7.64
    Bid:7.00 x 200
    Ask:10.40 x 1100
    1y Target Est:20.33
    Beta:6.83
    Next Earnings Date: 5-Aug-15KERX Earnings announcement
    Day's Range:7.55 - 7.92
    52wk Range:7.29 - 18.48
    Volume:840,559
    Avg Vol (3m):1,757,290
    Market Cap:802.87M
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KERX

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 0.39%802.87M
    BAXUp 3.92%21.75B
    SHPGDown 0.33%51.67B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):399.88
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.92
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-0.07

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback